Plandaí Biotechnology, Inc. (PLPL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 18, 2025, 4:00 PM EDT

Plandaí Biotechnology Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2016FY 2015FY 2014FY 2013FY 20122011
Period Ending
Sep '16 Jun '16 Jun '15 Jun '14 Jun '13 Jun '12 2011
Operating Revenue
0.230.190.010.270.360.07
Upgrade
Other Revenue
0.10.10.09---
Upgrade
0.340.30.090.270.360.07
Upgrade
Revenue Growth (YoY)
215.33%221.31%-65.04%-26.01%382.38%-
Upgrade
Cost of Revenue
0.910.940.790.950.96-
Upgrade
Gross Profit
-0.57-0.64-0.69-0.69-0.60.07
Upgrade
Selling, General & Admin
1.871.947.743.871.923.88
Upgrade
Operating Expenses
2.382.468.164.062.053.88
Upgrade
Operating Income
-2.95-3.11-8.85-4.74-2.66-3.81
Upgrade
Interest Expense
-1.97-1.79-0.93-1.03-0.31-0.03
Upgrade
Other Non Operating Income (Expenses)
-0.02-0.12-0-4.24-0
Upgrade
EBT Excluding Unusual Items
-4.93-5.01-9.78-10.01-2.97-3.84
Upgrade
Asset Writedown
----5.75--
Upgrade
Other Unusual Items
0.270.27-0.3-0.28--
Upgrade
Pretax Income
-4.66-4.74-10.07-16.05-2.97-3.84
Upgrade
Earnings From Continuing Operations
-4.66-4.74-10.07-16.05-2.97-3.84
Upgrade
Minority Interest in Earnings
0.340.360.490.440.780.06
Upgrade
Net Income
-4.32-4.38-9.58-15.61-2.19-3.78
Upgrade
Net Income to Common
-4.32-4.38-9.58-15.61-2.19-3.78
Upgrade
Shares Outstanding (Basic)
19617413711511196
Upgrade
Shares Outstanding (Diluted)
19617413711511196
Upgrade
Shares Change (YoY)
35.33%27.17%19.33%3.45%15.13%26.74%
Upgrade
EPS (Basic)
-0.02-0.03-0.07-0.14-0.02-0.04
Upgrade
EPS (Diluted)
-0.02-0.03-0.07-0.14-0.02-0.04
Upgrade
Free Cash Flow
-1-1.08-3.56-3.32-3.81-6.83
Upgrade
Free Cash Flow Per Share
-0.01-0.01-0.03-0.03-0.03-0.07
Upgrade
Gross Margin
-168.10%-215.98%--257.95%-168.20%100.00%
Upgrade
Operating Margin
-871.19%-1041.50%-9526.11%-1785.27%-740.03%-5117.09%
Upgrade
Profit Margin
-1275.88%-1467.07%-10315.03%-5873.14%-609.23%-5073.30%
Upgrade
Free Cash Flow Margin
-295.30%-362.92%-3833.01%-1249.98%-1059.98%-9168.49%
Upgrade
EBITDA
-2.44-2.59-8.44-4.56-2.52-3.81
Upgrade
D&A For EBITDA
0.510.520.410.190.140
Upgrade
EBIT
-2.95-3.11-8.85-4.74-2.66-3.81
Upgrade
Revenue as Reported
0.30.30.09---
Upgrade
Updated Mar 20, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.